Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $108.2 million.

  • Arcadia Biosciences' Non-cash Items rose 21416506.98% to $108.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.2 million, marking a year-over-year increase of 21416506.98%. This contributed to the annual value of $516.4 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Arcadia Biosciences reported Non-cash Items of $108.2 million as of Q3 2025, which was up 21416506.98% from $261.6 million recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Non-cash Items registered a high of $516.4 million during Q4 2024, and its lowest value of $25725.0 during Q1 2023.
  • For the 5-year period, Arcadia Biosciences' Non-cash Items averaged around $84.5 million, with its median value being $873633.0 (2022).
  • Per our database at Business Quant, Arcadia Biosciences' Non-cash Items plummeted by 9998.4% in 2023 and then soared by 21416506.98% in 2025.
  • Arcadia Biosciences' Non-cash Items (Quarter) stood at $501417.0 in 2021, then surged by 74.23% to $873633.0 in 2022, then tumbled by 95.95% to $35364.0 in 2023, then surged by 1460079.84% to $516.4 million in 2024, then crashed by 79.04% to $108.2 million in 2025.
  • Its Non-cash Items stands at $108.2 million for Q3 2025, versus $261.6 million for Q2 2025 and $40.8 million for Q1 2025.